TERT and breast carcinoma: Uno et al. conducted a subcellular localization analysis of TERT in 114 patients with breast cancer, specifically examining the luminal A (LA), luminal B (LB), HER2-overexpressing (HER2), and triple-negative (TN) subtypes [245].